Market Closed -
Other stock markets
|
Pre-market 08:37:06 am | |||
1.18 USD | -4.84% | 1.165 | -1.27% |
Apr. 22 | Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating | MT |
Apr. 22 | Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 304M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -72M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.13
x | P/E ratio 2025 * |
-4.45
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.51% |
Latest transcript on Ocugen, Inc.
1 day | -5.60% | ||
1 week | -18.06% | ||
Current month | -28.05% | ||
1 month | -28.05% | ||
3 months | +116.00% | ||
6 months | +198.58% | ||
Current year | +105.22% |
Managers | Title | Age | Since |
---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 60 | 12-12-31 |
Director of Finance/CFO | 42 | - | |
Jesse Simmers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 76 | 22-03-16 | |
Director/Board Member | 74 | 20-04-04 | |
Ramesh Kumar
BRD | Director/Board Member | 68 | 19-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.18 | -5.60% | 7,358,032 |
24-04-23 | 1.25 | +0.81% | 6,900,697 |
24-04-22 | 1.24 | -6.06% | 7,685,032 |
24-04-19 | 1.32 | 0.00% | 6,646,607 |
24-04-18 | 1.32 | -8.33% | 8,069,804 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+105.22% | 304M | |
+4.09% | 43.84B | |
+47.81% | 41.25B | |
+9.45% | 41.68B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+29.70% | 12.29B | |
+1.28% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- OCGN Stock